SummaryRMgm-307
|
Successful modification | The parasite was generated by the genetic modification |
The mutant contains the following genetic modification(s) | Gene disruption |
Reference (PubMed-PMID number) |
Reference 1 (PMID number) : 19779564 |
MR4 number | |
top of page | |
Parent parasite used to introduce the genetic modification | |
Rodent Malaria Parasite | P. berghei |
Parent strain/line | P. berghei ANKA |
Name parent line/clone | P. berghei ANKA 2.34 |
Other information parent line | P. berghei ANKA 2.34 is a cloned, gametocyte producer line of the ANKA strain (PubMed: PMID: 15137943). |
top of page | |
The mutant parasite was generated by | |
Name PI/Researcher | R.W. Moon; D.A. Baker; O. Billker |
Name Group/Department | Department of Cell and Molecular Biology |
Name Institute | Imperial College London |
City | London |
Country | UK |
top of page | |
Name of the mutant parasite | |
RMgm number | RMgm-307 |
Principal name | gcβ mutant |
Alternative name | |
Standardized name | |
Is the mutant parasite cloned after genetic modification | Yes |
top of page | |
Phenotype | |
Asexual blood stage | Not different from wild type |
Gametocyte/Gamete | Not different from wild type |
Fertilization and ookinete | Normal fertilisation rates and ookinete production. Ookinetes had a strongly reduced capacity to develop into oocysts (an oocyst production in Anopheles stephensi of only 2.2% of wild type oocysts). Mutant ookinetes had a greatly reduced gliding motility (speed). |
Oocyst | Ookinetes had a strongly reduced capacity to develop into oocysts (an oocyst production in Anopheles stephensi of only 2.2% of wild type oocysts). Mutant ookinetes had a greatly reduced gliding motility (speed). |
Sporozoite | Not tested |
Liver stage | Not tested |
Additional remarks phenotype | Mutant/mutation Injection of the mutant ookinetes into the hemocoel of mosquitoes did not result in formation of salivary gland sporozoites, suggesting that GCß may have an additional function. An independent unsuccessful attempt to disrupt the guanylyl cyclase-α gene is described in RMgm-323. |
top of page | |||||||||||||||||||||||||
Details of the target gene | |||||||||||||||||||||||||
Gene Model of Rodent Parasite | PBANKA_1136700 | ||||||||||||||||||||||||
Gene Model P. falciparum ortholog | PF3D7_1360500 | ||||||||||||||||||||||||
Gene product | guanylyl cyclase beta | ||||||||||||||||||||||||
Gene product: Alternative name | GCβ, guanylyl cyclase beta | ||||||||||||||||||||||||
top of page | |||||||||||||||||||||||||
Details of the genetic modification | |||||||||||||||||||||||||
Inducable system used | No | ||||||||||||||||||||||||
Additional remarks inducable system | |||||||||||||||||||||||||
Type of plasmid/construct used | Plasmid single cross-over | ||||||||||||||||||||||||
PlasmoGEM (Sanger) construct/vector used | No | ||||||||||||||||||||||||
Modified PlasmoGEM construct/vector used | No | ||||||||||||||||||||||||
Plasmid/construct map | |||||||||||||||||||||||||
Plasmid/construct sequence | |||||||||||||||||||||||||
Restriction sites to linearize plasmid | ClaI | ||||||||||||||||||||||||
Partial or complete disruption of the gene | Partial | ||||||||||||||||||||||||
Additional remarks partial/complete disruption | |||||||||||||||||||||||||
Selectable marker used to select the mutant parasite | tgdhfr | ||||||||||||||||||||||||
Promoter of the selectable marker | pbdhfr | ||||||||||||||||||||||||
Selection (positive) procedure | pyrimethamine | ||||||||||||||||||||||||
Selection (negative) procedure | No | ||||||||||||||||||||||||
Additional remarks genetic modification | The gcβ gene has been disrupted using a construct that integrates by single cross-over integration (insertion vector) that contains the tgdhfr selectable marker. The disadvantage of using an insertion construct is that the construct can be removed from the genome, thereby restoring the wild type genotype. | ||||||||||||||||||||||||
Additional remarks selection procedure | |||||||||||||||||||||||||
Primer information: Primers used for amplification of the target sequences
Primer information: Primers used for amplification of the target sequences
| |||||||||||||||||||||||||
top of page |